Clinical presentation and laboratory diagnosis of heparin-induced thrombocytopenia (original) (raw)

Heparin-Induced Thrombocytopenia (HIT)

Tomislav Vuk

Anticoagulant Drugs, 2018

View PDFchevron_right

Heparin-induced Thrombocytopenia (HIT) in Cardiovascular Medicine

Patricia French

2001

View PDFchevron_right

Heparin-induced thrombocytopenia

matija kozak

Clinical Pharmacist, 2017

View PDFchevron_right

Heparin-induced thrombocytopenia: natural history, diagnosis, and management

Teresa Carman

Vascular Medicine, 2001

View PDFchevron_right

Heparin-induced thrombocytopenia: principles for early recognition and management

Amjad Almahameed

Cleveland Clinic Journal of Medicine, 2005

View PDFchevron_right

Heparin Induced Thrombocytopenia: Can Be Excluded

Nissar Shaikh

Journal of Blood Disorders & Transfusion, 2013

View PDFchevron_right

Heparin-Induced Thrombocytopenia: A Review for Cardiac Anesthesiologists and Intensivists

John Klick

Journal of Cardiothoracic and Vascular Anesthesia, 2018

View PDFchevron_right

Heparin-induced thrombocytopenia (HIT): Identification and treatment pathways

Mahmoud Fathi

Global cardiology science & practice, 2018

View PDFchevron_right

Diagnosis and treatment of heparin-induced thrombocytopenia

Jun-li Liu

Perfusion, 2003

View PDFchevron_right

Urgent Cardiac Surgery in a Patient with a Remote History of Heparin-Induced Thrombocytopenia: Use of the Anti-PF4/Heparin ELISA Confirmatory Test

Philip Greilich

Anesthesia & Analgesia, 2008

View PDFchevron_right

Case report Can thromboelastography predict which patients with heparin-induced thrombocytopenia may suffer thrombotic complications of type II?

Nikolaos Theakos, Ilias Kouerinis

2010

View PDFchevron_right

Heparin‐Induced Thrombocytopenia: Pathophysiology, Diagnosis, and Treatment Monitoring

Dimitrios Stylos

Drug Development Research, 2013

View PDFchevron_right

Evaluating Heparin-Induced Thrombocytopenia: The Old and the New

M. Morel-Kopp

Seminars in Thrombosis and Hemostasis, 2012

View PDFchevron_right

Heparin-induced thrombocytopenia: Pathophysiology and new treatment options

Job Harenberg

Pathophysiology of Haemostasis and Thrombosis, 2002

View PDFchevron_right

Heparin-induced thrombocytopenia thrombosis after cardiac surgery. A case report

Dr.Eman Younis

Acta Anaesthesiologica Scandinavica, 2000

View PDFchevron_right

Thrombocytopenia Following Heparin Flush

Eliezer Katz

Progress in Cardiovascular Nursing, 2005

View PDFchevron_right

The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-induced Thrombocytopenia

Vishal Jindal

Cureus, 2018

View PDFchevron_right

Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis

B. Chong

Journal of Thrombosis and Haemostasis, 2011

View PDFchevron_right

Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia

angela rogolino

Journal of Clinical Medicine, 2020

View PDFchevron_right

Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines

W. Elliott

European Journal of Cardio-Thoracic Surgery, 2005

View PDFchevron_right

Can thromboelastography predict which patients with heparin-induced thrombocytopenia may suffer thrombotic complications of type II?

Nikolaos Theakos, Ilias Kouerinis

European Journal of Cardio-Thoracic Surgery, 2007

View PDFchevron_right

Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: Implications in the HIT pathogenesis

Sarfraz Ahmad

Molecular and Cellular Biochemistry, 2000

View PDFchevron_right

Prevalence, isotype, and functionality of antiheparin–platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia

Sarfraz Ahmad

Thrombosis Research, 2002

View PDFchevron_right

Heparin-induced thrombocytopenia in children

Fiona Newall

Journal of Paediatrics and Child Health, 2003

View PDFchevron_right

Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients

Bernhard Lämmle

Haematologica, 2012

View PDFchevron_right

Heparin induced thrombocytopenia: A case-based re-appraisal

Rajeev Bhardwaj

Clinical Case Studies and Reports

View PDFchevron_right

Identification, Diagnosis and Treatment of Heparin-induced Thrombocytopenia and Thrombosis: A Registry of Prolonged Heparin Use and Thrombocytopenia among Hospitalized Patients with and without Cardiovascular Disease

Lawrence Rice

Journal of Thrombosis and Thrombolysis, 2005

View PDFchevron_right

Update on Mechanisms, Pathogenicity, Heterogeneity of Presentation, and Laboratory Diagnosis of Heparin-Induced Thrombocytopenia

Jean AMIRAL

Anticoagulation drugs - the Current State of the Art [Working Title]

View PDFchevron_right

Joanna Zdziarska

Kardiologia Polska

View PDFchevron_right

Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia

Vishal Jindal

Journal of Blood Medicine, 2020

View PDFchevron_right

Pathophysiology, epidemiology, diagnosis and treatment of heparin-induced thrombocytopenia (HIT)

Birgit Gathof

European journal of medical research, 2004

View PDFchevron_right

Incidence of Antiheparin−Platelet Factor 4 Antibodies and Heparin-Induced Thrombocytopenia in Turkish Patients Undergoing Cardiac Surgery

Muzaffer Turgut

Clinical and Applied Thrombosis-hemostasis, 2007

View PDFchevron_right

Pathogenic heparin‐induced thrombocytopenia and thrombosis (HIT) antibodies determined by rapid functional flow cytometry

Varda Deutsch

European Journal of Haematology, 2019

View PDFchevron_right

Obstacles in the diagnostics and therapy of heparin-induced thrombocytopenia

Slobodan Obradovic

Srpski arhiv za celokupno lekarstvo, 2010

View PDFchevron_right

Clinical presentation and laboratory diagnosis of heparin-induced thrombocytopenia (original) (raw)

Related papers